Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine
- 16 November 2009
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 27 (49), 6845-6853
- https://doi.org/10.1016/j.vaccine.2009.09.017
Abstract
No abstract availableKeywords
Funding Information
- NIH (HL28220)
This publication has 37 references indexed in Scilit:
- A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 VaccineJournal of Virology, 2008
- Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4(+) T cellsImmunity, 2008
- An HSV-1 gD mutant virus as an entry-impaired live virus vaccineVaccine, 2008
- Rates of Reactivation of Latent Herpes Simplex Virus from Mouse Trigeminal Ganglia Ex Vivo Correlate Directly with Viral Load and Inversely with Number of Infiltrating CD8+T CellsJournal of Virology, 2007
- A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boostVaccine, 2007
- Protective immune responses against West Nile virus are primed by distinct complement activation pathwaysThe Journal of Experimental Medicine, 2006
- A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigsVaccine, 2001
- Species selective interaction of Alphaherpesvirinae with the “unspecific” immune system of the hostArchiv für die gesamte Virusforschung, 1993
- Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cellsNature, 1984
- Genetics of natural resistance to herpesvirus infections in miceNature, 1975